reported that members of the miR-200 family (specifically, miR-200b and miR-200c) play crucial roles in regulating the EMT process and the sensitivity of BC cells to epidermal growth factor receptor (EGFR)-targeted therapy (112). Here, EGFR is linked to breast cancer.